Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug
Stock Soars on Major Funding News Minerva Neurosciences’ stock chart went vertical on Tuesday after the biotech announced an expansive financing deal that effectively triples the company’s market capitalization overnight marketbeat.com. In